BBInternational Join EMD Millipore and Kinematic for San Diego Seminar on Lateral Flow
BBI join EMD Millipore and Kinematic to educate in the field of lateral flow and ensuring faster, higher performing and more robust systems.
Cardiff (I-Newswire) September 12, 2012 - The October seminar will educate registrants on how to develop and manufacture a lateral flow test and provide new insights into how superior quality components, established research and development processes and highly efficient machinery, guarantee faster, higher performing and more robust assay systems.
The practical elements of the course will allow theory to be put into practice as a lateral flow test is built; culminating with the end user being able to read this test with BBI’s new Novarum smartphone reader.
The Seminar, taking place on the 2nd and 3rd October in San Diego, incorporates BBI’s understanding of market requirements as well as the available new technologies which are enhancing lateral flow. “We are constantly updating lateral flow technology to improve performance whilst ensuring the cost per test allows for market penetration” commented Morag Leaver, BBI’s Head of R&D. “This seminar will allow us to share our experience and highlight the advancements within the field of lateral flow”.
The seminar is designed for professionals involved in the development and manufacture of lateral flow test kits. Scientists, engineers and technicians working in R&D and product development will also benefit. Presentations are by PATH, EMD Millipore, BBInternational and Kinematic.
In more detail, the seminar will cover the following elements, providing an all-encompassing perspective for those working towards development of the best performing assay.
• Contract R&D for lateral flow – design phases, qualitative versus quantitative assays plus regulatory considerations
• Design considerations for lateral flow test strips
• Design for manufacturability
• Membrane technology - manufacturing, properties, testing, storage and handling
• Reagent chemistries and labels of choice for lateral flow
• Antibodies and blockers
• Matrix modules, primer to lab, striping machinery and settings
• Pad materials – important properties and selection
• QC testing considerations – patient samples,
• Contract manufacturing and test validation
• Equipment validation
• NEW Novarum Reader, molecular and future technologies
The event will also provide networking opportunities in the form of a cocktail and canapé reception on the first evening. For more information visit http://www.bbigold.com/seminar.
BBInternational is a leading global supplier and manufacturer of high quality gold reagents which ar More..e used within lateral flow rapid diagnostic tests at the point of care (POC). Over the years BBInterational – with its own unique recipe gold colloid – has developed an enviable reputation as the supplier of choice in the global diagnostics marketplace.Less..
73 Ty Glas Avenue
Phone : +44 (0) 2920 747232
Published in:Science and Research
Published On:September 12, 2012
Print Release:Print Release
If you have questions regarding information in this press release contact the company listed above. I-Newswire.com is a press release service and not the author of this press release.The information that is on or available through this site is for informational purposes only and speaks only as of the particular date or dates of that information. As some companies and PR Agencies submit their press releases once per week,month or quarter, make sure to check the official company website for accurate release dates as our site displays the I-Newswire.com press release distribution date only.We do not guarantee the accuracy or completeness of information on or available through this site, and we are not responsible for or omissions in that information or for actions taken in reliance on that information.
F1000Research Aims to Reduce Publication Bias
Phare Consulting Pushes For Comprehensive Growth In the Security Manufacturing Sector
Differentiated & Focused Conference On Polymeric Materials In Medical Devices Undefined. San Francisco, CA, USA, JUNE 26-28, 2013
Capital Resource Partners Purchases Gamma Medica’s Pre-Clinical Business to Form New Entity, Trifoil Imaging
Well Intervention Market Worth $17.48 Billion By 2018